Citadel Advisors’s OmniAb OABI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,900
Closed -$6.96K 14301
2025
Q1
$6.96K Sell
2,900
-7,000
-71% -$22.9K ﹤0.01% 13718
2024
Q4
$35K Sell
9,900
-13,200
-57% -$52.2K ﹤0.01% 12733
2024
Q3
$97.7K Sell
23,100
-6,200
-21% -$26.8K ﹤0.01% 11143
2024
Q2
$110K Buy
29,300
+21,200
+262% +$96.6K ﹤0.01% 10780
2024
Q1
$43.9K Buy
8,100
+1,700
+27% +$9.79K ﹤0.01% 12297
2023
Q4
$39.5K Sell
6,400
-7,500
-54% -$36.9K ﹤0.01% 12027
2023
Q3
$72.1K Buy
13,900
+2,200
+19% +$11.7K ﹤0.01% 11296
2023
Q2
$58.9K Buy
11,700
+11,400
+3,800% +$46.2K ﹤0.01% 11612
2023
Q1
$1.1K Sell
300
-4,310
-93% -$16.3K ﹤0.01% 14360
2022
Q4
$16.6K Buy
+4,610
New +$24.2K ﹤0.01% 13275

Other funds holding OABI

Citadel Advisors's OABI Position: Q1 2026 in Review

Citadel Advisors reduced its OmniAb (OABI) stake by 20% in Q1 2026, selling an estimated $102K and leaving 228,684 shares worth $359K. The position accounts for ﹤0.01% of the portfolio, ranked #10061.

Citadel Advisors first reported a position in OABI in Q4 2021 and has held it in 16 quarters since. The position peaked at $13.3M in Q4 2021. 128 funds tracked by Wall St. Rank hold OABI as of Q1 2026.

  • Citadel Advisors held 228,684 shares of OmniAb worth $359K as of Q1 2026.
  • Citadel Advisors sold 56,450 OmniAb shares in Q1 2026, an estimated $102K.
  • OmniAb made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #10061 holding.
  • Citadel Advisors first reported a position in OmniAb in Q4 2021 and has held it in 16 quarters since.
  • Citadel Advisors's OmniAb position peaked at $13.3M in Q4 2021.
  • 128 funds tracked by Wall St. Rank held OmniAb as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.